ASND (ASND) Stock Price & Analysis
ASND (ASND) fell 0.21% to USD 270.56 as of September 8, 2026 at 04:20 UTC, according to Nexqual real-time market data.
ASND last closed at USD 270.56; the session ranged USD 265.22–271.14 on volume of 723,515 shares. Market capitalization is —, with a 52-week range of USD 186.05–282.15 (NMS). Source: Nexqual, September 8, 2026 at 04:20 UTC.
Key Statistics (as of September 8, 2026 at 04:20 UTC)
| Price | USD 270.56 |
|---|---|
| Change | ▼ 0.21% (down) |
| Previous Close | USD 270.56 |
| Open | USD 270.56 |
| Day Range | USD 265.22 – 271.14 |
| 52-Week Range | USD 186.05 – 282.15 |
| Volume | 723,515 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ASND)
Nexqual's technical model rates ASND "BUY" based on 5 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 04:20 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 65.13 (neutral) |
| vs SMA50 | Above (USD 257.57) |
| MACD | 3.83 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ARGX | argenx SE | USD 1,033.15 | ▼ 2.11% |
| KRYS | Krystal Biotech, Inc. | USD 358.24 | ▼ 2.98% |
| RARE | Ultragenyx Pharmaceutical Inc. | USD 15.3 | ▼ 42.33% |
| BBIO | BridgeBio Pharma, Inc. | USD 74.84 | ▼ 2.17% |
| MDGL | Madrigal Pharmaceuticals, Inc. | USD 541.08 | ▼ 1.07% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:20 UTC. This page is informational and not investment advice.